The company’s flagship product, fatty15, earned the Mindful Award for Wellness Company of the Year and the Beauty Shortlist 15th Anniversary Wellbeing award. Additionally, Global Health & Pharma (GHP) recognized the brand as the top essential fatty acid supplement while granting it an excellence award for customer satisfaction. These honors arrive amid a surge in the product's popularity, supported by a 95% monthly retention rate among its 100,000 active subscribers.

Dr. Eric Venn-Watson, co-founder and co-CEO of Seraphina Therapeutics, attributed the success to a decade of rigorous research into C15:0, or pentadecanoic acid. The nutrient, which is backed by over 150 peer-reviewed studies, is marketed as a foundational supplement to support cellular health, metabolic function, and immune balance. Beyond industry recognition, the product recently achieved a 9.88 trust score from SuppCo Certified, placing it in the top 1% of over 160,000 supplements evaluated. As the company continues to scale, it maintains that its core mission remains the integration of scientific discovery into accessible, daily nutritional routines.